- Home
- JRSH vs MRSN Comparison
JRSH vs MRSN Comparison
Compare JRSH & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- MRSN
- Stock Information
- Founded
- JRSH 2016
- MRSN 2001
- Country
- JRSH United States
- MRSN United States
- Employees
- JRSH N/A
- MRSN N/A
- Industry
- JRSH Apparel
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- JRSH Consumer Discretionary
- MRSN Health Care
- Exchange
- JRSH Nasdaq
- MRSN Nasdaq
- Market Cap
- JRSH 41.7M
- MRSN 37.0M
- IPO Year
- JRSH 2018
- MRSN 2017
- Fundamental
- Price
- JRSH $3.27
- MRSN $9.28
- Analyst Decision
- JRSH Strong Buy
- MRSN Strong Buy
- Analyst Count
- JRSH 1
- MRSN 3
- Target Price
- JRSH $4.00
- MRSN $33.00
- AVG Volume (30 Days)
- JRSH 124.5K
- MRSN 41.5K
- Earning Date
- JRSH 11-11-2025
- MRSN 11-12-2025
- Dividend Yield
- JRSH 6.12%
- MRSN N/A
- EPS Growth
- JRSH N/A
- MRSN N/A
- EPS
- JRSH 0.07
- MRSN N/A
- Revenue
- JRSH $144,505,598.00
- MRSN $34,769,000.00
- Revenue This Year
- JRSH $7.62
- MRSN N/A
- Revenue Next Year
- JRSH $8.35
- MRSN N/A
- P/E Ratio
- JRSH $49.84
- MRSN N/A
- Revenue Growth
- JRSH 17.11
- MRSN 16.14
- 52 Week Low
- JRSH $2.81
- MRSN $5.21
- 52 Week High
- JRSH $4.17
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- JRSH 46.71
- MRSN 62.93
- Support Level
- JRSH $3.23
- MRSN $7.85
- Resistance Level
- JRSH $3.35
- MRSN $8.35
- Average True Range (ATR)
- JRSH 0.10
- MRSN 0.37
- MACD
- JRSH -0.01
- MRSN 0.00
- Stochastic Oscillator
- JRSH 38.09
- MRSN 77.70
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.